Skip to main content
Top
Published in: Supportive Care in Cancer 9/2009

01-09-2009 | Original Article

Individualised and complex experiences of integrative cancer support care: combining qualitative and quantitative data

Authors: Helen E. Seers, Nicola Gale, Charlotte Paterson, Helen J. Cooke, Veronica Tuffrey, Marie J. Polley

Published in: Supportive Care in Cancer | Issue 9/2009

Login to get access

Abstract

Objectives

The widespread use of complementary therapies alongside biomedical treatment by people with cancer is not supported by evidence from clinical trials. We aimed to use combined qualitative and quantitative data to describe and measure individualised experiences and outcomes.

Materials and methods

In three integrative cancer support centres (two breast cancer only) in the UK, consecutive patients completed the individualised outcome questionnaire Measure Yourself Concerns and Wellbeing (MYCaW) before and after treatment. MYCaW collects quantitative data (seven-point scales) and written qualitative data and the qualitative data were analysed using published categories.

Results

Seven hundred eighty-two participants, 92% female, mean age 51 years, nominated a wide range of concerns. Psychological and emotional concerns predominated. At follow-up, the mean change (improvement) in scores (n = 588) were: concern 1, 2.06 (95% CI 1.92–2.20); concern 2, 1.74 (95% CI 1.60–1.90); and well-being, 0.64 (95% CI 0.52–0.75). The most common responses to ‘what has been the most important aspect for you?’ were ‘receiving complementary therapies on an individual or group basis’ (26.2%); ‘support and understanding received from therapists’ (17.1%) and ‘time spent with other patients at the centres’ (16.1%). Positive (61.5%) and negative (38.5%) descriptions of ‘other things affecting your health’ correlated with larger and smaller improvement in concerns and well-being, respectively.

Conclusions

In a multicentre evaluation, the MYCaW questionnaire provides rich data about patient experience, changes over time and perceptions of what was important to each individual with cancer within that experience. It is unlikely that meaningful evaluations of this complex intervention could be carried out by quantitative methods alone.
Literature
1.
go back to reference Downer SM, Cody MM, McCluskey P, Wilson PD, Arnott SJ, Lister TA et al (1994) Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ 309:86–89PubMed Downer SM, Cody MM, McCluskey P, Wilson PD, Arnott SJ, Lister TA et al (1994) Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ 309:86–89PubMed
2.
go back to reference Verhoef M, Balneaves LG, Boon H, Vroegindewey A (2005) Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review. Integr Cancer Ther 4:274–286PubMedCrossRef Verhoef M, Balneaves LG, Boon H, Vroegindewey A (2005) Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review. Integr Cancer Ther 4:274–286PubMedCrossRef
3.
go back to reference Evans M, Shaw A, Thompson EA, Falk S, Turton P, Thompson T, Sharp D (2007) Decisions to use complementary and alternative medicine (CAM) by male cancer patients: information-seeking roles and types of evidence used. BMC Complementary and Alternative Medicine 7:25 (Aug 4). doi:10.1186/1472-6882-7-25 PubMedCrossRef Evans M, Shaw A, Thompson EA, Falk S, Turton P, Thompson T, Sharp D (2007) Decisions to use complementary and alternative medicine (CAM) by male cancer patients: information-seeking roles and types of evidence used. BMC Complementary and Alternative Medicine 7:25 (Aug 4). doi:10.​1186/​1472-6882-7-25 PubMedCrossRef
4.
go back to reference Correa-Velez I, Clavarino A, Eastwood H (2005) Surviving, relieving, repairing, and boosting up: reasons for using complementary/alternative medicine among patients with advanced cancer: a thematic analysis. J Palliat Med 8:953–961. doi:10.1089/jpm.2005.8.953 PubMedCrossRef Correa-Velez I, Clavarino A, Eastwood H (2005) Surviving, relieving, repairing, and boosting up: reasons for using complementary/alternative medicine among patients with advanced cancer: a thematic analysis. J Palliat Med 8:953–961. doi:10.​1089/​jpm.​2005.​8.​953 PubMedCrossRef
5.
go back to reference Lengacher CA, Bennett MP, Kip KE, Gonzalez L, Jacobsen P, Cox CE (2006) Relief of symptoms, side effects, and psychological distress through use of complementary and alternative medicine in women with breast cancer. Oncol Nurs Forum 33:97–104. doi:10.1188/06.ONF.97-104 PubMedCrossRef Lengacher CA, Bennett MP, Kip KE, Gonzalez L, Jacobsen P, Cox CE (2006) Relief of symptoms, side effects, and psychological distress through use of complementary and alternative medicine in women with breast cancer. Oncol Nurs Forum 33:97–104. doi:10.​1188/​06.​ONF.​97-104 PubMedCrossRef
6.
go back to reference National Institute for Clinical Excellence (2004) Improving supportive and palliative care for adults with cancer: the manual. National Institute for Clinical Excellence, London National Institute for Clinical Excellence (2004) Improving supportive and palliative care for adults with cancer: the manual. National Institute for Clinical Excellence, London
7.
go back to reference Ernst E, Cassileth BR (1998) The prevalence of complementary and alternative cancer: a systematic review. Cancer 53:2736–2740 Ernst E, Cassileth BR (1998) The prevalence of complementary and alternative cancer: a systematic review. Cancer 53:2736–2740
8.
go back to reference Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott GA, Panteli V et al (2005) Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 16:663. doi:10.1093/annonc/mdi110 CrossRef Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott GA, Panteli V et al (2005) Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 16:663. doi:10.​1093/​annonc/​mdi110 CrossRef
13.
go back to reference Black N (1996) Why we need observational studies to evaluate the effectiveness of health care. BMJ 312:1215–1218PubMed Black N (1996) Why we need observational studies to evaluate the effectiveness of health care. BMJ 312:1215–1218PubMed
14.
16.
go back to reference Rosenbaum E, Gautier H, Fobair P, Neri E, Festa B, Hawn M, Andrews A, Hirshberger N, Selim S, Spiegel D (2004) Cancer supportive care, improving the quality of life for cancer patients. A program evaluation report. Support Care Cancer 12(5):293–301. doi:10.1007/s00520-004-0599-0 PubMedCrossRef Rosenbaum E, Gautier H, Fobair P, Neri E, Festa B, Hawn M, Andrews A, Hirshberger N, Selim S, Spiegel D (2004) Cancer supportive care, improving the quality of life for cancer patients. A program evaluation report. Support Care Cancer 12(5):293–301. doi:10.​1007/​s00520-004-0599-0 PubMedCrossRef
17.
go back to reference Paterson C, Thomas K, Manasse A, Cooke H, Peace G (2007) Measure Yourself Concerns and Wellbeing (MYCaW): an individualised questionnaire for evaluating outcome in cancer support care that includes complementary therapies. Complement Ther Med 15:38–45. doi:10.1016/j.ctim.2006.03.006 PubMedCrossRef Paterson C, Thomas K, Manasse A, Cooke H, Peace G (2007) Measure Yourself Concerns and Wellbeing (MYCaW): an individualised questionnaire for evaluating outcome in cancer support care that includes complementary therapies. Complement Ther Med 15:38–45. doi:10.​1016/​j.​ctim.​2006.​03.​006 PubMedCrossRef
19.
20.
go back to reference Paterson C (1996) Measuring outcome in primary care: a patient-generated measure, MYMOP, compared to the SF-36 health survey. BMJ 312:1016–1020PubMed Paterson C (1996) Measuring outcome in primary care: a patient-generated measure, MYMOP, compared to the SF-36 health survey. BMJ 312:1016–1020PubMed
21.
go back to reference Paterson C, Langan CE, McKaig GA, Anderson GDH, Maclaine GDH, Rose LH (2000) Assessing patient outcomes in acute exacerbations of chronic bronchitis: the measure yourself medical outcome profile (MYMOP), medical outcomes study 6-item general health survey (MOS-6) and EuroQol (EQ-5D). Qual Life Res 9:521–527. doi:10.1023/A:1008930521566 PubMedCrossRef Paterson C, Langan CE, McKaig GA, Anderson GDH, Maclaine GDH, Rose LH (2000) Assessing patient outcomes in acute exacerbations of chronic bronchitis: the measure yourself medical outcome profile (MYMOP), medical outcomes study 6-item general health survey (MOS-6) and EuroQol (EQ-5D). Qual Life Res 9:521–527. doi:10.​1023/​A:​1008930521566 PubMedCrossRef
23.
go back to reference Guyatt GH, Juniper EF, Walter S, Griffith L, Goldstein RS (1998) Interpreting treatment effects in randomised trials. BMJ 316:690–693PubMed Guyatt GH, Juniper EF, Walter S, Griffith L, Goldstein RS (1998) Interpreting treatment effects in randomised trials. BMJ 316:690–693PubMed
24.
go back to reference Fasching PA, Theil F, Nicolaisen-Murmann K, Rauh C, Engel J, Lux MP et al (2007) Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies. Support Care Cancer 15:1277–1284. doi:10.1007/s00520-007-0231-1 PubMedCrossRef Fasching PA, Theil F, Nicolaisen-Murmann K, Rauh C, Engel J, Lux MP et al (2007) Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies. Support Care Cancer 15:1277–1284. doi:10.​1007/​s00520-007-0231-1 PubMedCrossRef
28.
go back to reference Shaw A, Evans M, Sharp D, Thompson EA, Falk S, Turton P et al (2006) Male cancer patients’ views on and use of complementary and alternative medicine (CAM): a qualitative study. Final Report to the Department of Health. Department of Health, London Shaw A, Evans M, Sharp D, Thompson EA, Falk S, Turton P et al (2006) Male cancer patients’ views on and use of complementary and alternative medicine (CAM): a qualitative study. Final Report to the Department of Health. Department of Health, London
29.
go back to reference Steinsbekk A, Launso L (2005) Empowering the cancer patient or controlling the tumor? A qualitative study of how cancer patients experience consultations with complementary and alternative medicine practitioners and physicians, respectively. Integr Cancer Ther 4:195–200. doi:10.1177/1534735405276721 PubMedCrossRef Steinsbekk A, Launso L (2005) Empowering the cancer patient or controlling the tumor? A qualitative study of how cancer patients experience consultations with complementary and alternative medicine practitioners and physicians, respectively. Integr Cancer Ther 4:195–200. doi:10.​1177/​1534735405276721​ PubMedCrossRef
Metadata
Title
Individualised and complex experiences of integrative cancer support care: combining qualitative and quantitative data
Authors
Helen E. Seers
Nicola Gale
Charlotte Paterson
Helen J. Cooke
Veronica Tuffrey
Marie J. Polley
Publication date
01-09-2009
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 9/2009
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-008-0565-3

Other articles of this Issue 9/2009

Supportive Care in Cancer 9/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine